Institutions · Entity Annotation Prototype (beta)

4articles mentioning institutions

5institution mentions

1distinct institutions extracted

0%of mentions human-reviewed

Active filtersEntity: University of Sydney ×

University of Sydney

This institution is selected. Its supporting articles are shown below.

University of Sydney4

Articles mentioning University of Sydney

4 articles · page 1 of 1

741 Correlation between protein expression in immune cell populations and circulating glycopeptide biomarkers differs with response to checkpoint inhibitor treatment in advanced lung cancer

jitc · abstract · 2025-11-04 · 2 matching annotations

92.5%

University of Sydney The Translational Immunology Laboratory lung cancer Pembrolizumab Durvalumab Nivolumab

…were provided by The Translational Immunology Laboratory at the University of Sydney. The cohort consisted of 18 males and 13 females, with ages ran…

SAGE (safer analgesia): a protocol for a pragmatic cluster randomised controlled trial to reduce the use of high-risk medicines in people with chronic back and/or neck pain

bmjopen · abstract · 2026-05-24 · 1 matching annotations

79.4%

University of Sydney SAGE intervention Chronic back and neck pain chronic back and/or neck pain opioid analgesics diclofenac gel gabapentinoids benzodiazepines Deprescribing interventions gabapentinoid

…y.Ethics and dissemination The study received approval from the University of Sydney Human Research Ethics Committee (2024/HE001706). The results wi…

Implementation of an Australian helpline for low back pain: protocol of a type 2 hybrid effectiveness-implementation trial

bmjopen · abstract · 2025-12-02 · 1 matching annotations

92.6%

University of Sydney Low back pain

…asures.Ethics and dissemination The project was approved by the University of Sydney’s Human Research Ethics Committee (HE001081). This project invo…

40 Blood-based proteomic and glycoproteomic biomarkers exhibit promising additivity in predicting response in checkpoint inhibitor treated lung cancer

jitc · abstract · 2025-11-04 · 1 matching annotations

92.0%

Translational Immunology Laboratory University of Sydney Pembrolizumab lung cancer Durvalumab Nivolumab The University of Sydney Ethics Board

…and n=29 ICI+chemo). Pre-treatment samples were provided by the Translational Immunology Laboratory at the University of Sydney. The cohort consisted of 21 males a…